The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice

Bone

Volumn 48, Issue 6, 2011, Pages 1362-1369

  Liang, Qian Qian ^a   Li, Xiao Feng ^a   Zhou, Quan ^a   Xing, Lianping ^b   Cheng, Shao Dan ^a   Ding, Dao Fang ^a   Xu, Le Qin ^a   Tang, De Zhi ^a   Bian, Qin ^a   Xi, Zhi Jie ^a   Zhou, Chongjian ^a   Shi, Qi ^a   Wang, Yong Jun ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cartilage endplate; Intervertebral disc; Intervertebral disc degeneration; Osteoclast; Osteoprotegerin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AGGRECAN; ALKALINE PHOSPHATASE BONE ISOENZYME; CATHEPSIN K; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGENASE 3; GELATINASE B; MESSENGER RNA; OSTEOCALCIN; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR OSTERIX;

AGED; AGING; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE REMODELING; CARTILAGE CELL; CELL COUNT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MOUSE; NERVE ENDING; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CARTILAGE; DNA PRIMERS; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERVERTEBRAL DISK; MICE; MICE, KNOCKOUT; OSTEOPROTEGERIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79955917758     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.03.773     Document Type: Article

References (31)

1. Weiler C., Nerlich A.G., Schaaf R., Bachmeier B.E., Wuertz K., Boos N. Immunohistochemical identification of notochordal markers in cells in the aging human lumbar intervertebral disc. Eur Spine J 2010, 19(10):1761-1770.
2. Cummings S.R., Kelsey J.L., Nevitt M.C., O'Dowd K.J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985, 7:178-208.
3. Pollintine P., Dolan P., Tobias J.H., Adams M.A. Intervertebral disc degeneration can lead to "stress-shielding" of the anterior vertebral body: a cause of osteoporotic vertebral fracture?. Spine (Phila Pa 1976) 2004, 29(7):774-782.
4. Gruber H.E., Gordon B., Williams C., Norton H.J., Hanley E.N. Correlation between bone mineral density and intervertebral disc degeneration. Spine (Phila Pa 1976) 2007, 32(23):2529-2536.
5. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423(6937):337-342.
6. Mitchner N.A., Harris S.T. Current and emerging therapies for osteoporosis. J Fam Pract 2009, 58(7 Suppl Osteoporosis):S45-S49.
7. Kwan Tat S., Amiable N., Pelletier J.P., Boileau C., Lajeunesse D., Duval N., et al. Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford) 2009, 48(12):1482-1490.
8. Mackiewicz Z., Salo J., Konttinen Y.T., Kaigle Holm A., Indahl A., Pajarinen J., et al. Receptor activator of nuclear factor kappa B ligand in an experimental intervertebral disc degeneration. Clin Exp Rheumatol 2009, 27(2):299-306.
9. Spahni A.I., Schawalder P., Rothen B., Bosshardt D.D., Lang N., Stoffel M.H. Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints. Vet Surg 2009, 38(6):780-786.
10. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12:1260-1268.
11. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 1998, 247:610-615.
12. Nakamura M., Udagawa N., Matsuura S., Mogi M., Nakamura H., Horiuchi H., et al. Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 2003, 144:5441-5449.
13. Hunter C.J., Matyas J.R., Duncan N.A. The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. Tissue Eng 2003, 9(4):667-677.
14. Ota N., Takaishi H., Kosaki N., Takito J., Yoda M., Tohmonda T., et al. Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice. Endocrinology 2009, 150(11):4823-4834.
15. Takuma S. Electron microscopy of cartilage resorption by chondroclasts. J Dent Res 1962, 41:883-889.
16. Knese K.H. Osteoclasts, chondroclasts, mineraloclasts, collagenoclasts. Acta Anat (Basel) 1972, 83(2):275-288.
17. Nordahl J., Andersson G., Reinholt F.P. Chondroclasts and osteoclasts in bones of young rats: comparison of ultrastructural and functional features. Calcif Tissue Int 1998, 63(5):401-408.
18. Wang Zhao-Qi, Ovitt Catherine, Grigoriadis Agamemnon E., Möhle-Steinlein Uta, Rüther Ulrich, Wagner Erwin F. Bone and haematopoietic defects in mice lacking c-fos. Nature 1992, 360(6406):741-745.
19. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000, 97(4):1566-1571.
20. Odgren P.R., Kim N., MacKay C.A., Mason-Savas A., Choi Y., Marks S.C. The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res 2003, 44(Suppl 1):264-271.
21. Xing L., Yamashita T., Childs L., Schwarz E.M., O'Keefe R.J., Dougall W.C., et al. RANKL/RANK/NF-kB signaling regulates chondrogenesis. Concurrent Oral Session C20 of The 24th Annual meeting of the American Society for Bone and Mineral Research, San Antonio, TX, USA, September 2002.
22. Katz M.M., Hargens A.R., Garfin S.R. Intervertebral disc nutrition: diffusion versus convection. Clin Orthop Relat Res 1986, 210:243-245.
23. Urban J.P., Smith S., Fairbank J.C. Nutrition of the intervertebral disc. Spine 2004, 29:2700-2709.
24. Holm S., Holm A.K., Ekström L., Karladani A., Hansson T. Experimental disc degeneration due to endplate injury. J Spinal Disord Tech 2004, 17(1):64-71.
25. Turgut M., Uslu S., Uysal A., Yurtseven M.E., Ustün H. Changes in vascularity of cartilage endplate of degenerated intervertebral discs in response to melatonin administration in rats. Neurosurg Rev 2003, 26(2):133-138.
26. Oegema T.R. The role of disc cell heterogeneity in determining disc biochemistry: a speculation. Biochem Soc Trans 2002, 30:839-844.
27. Sive J.I., Baird P., Jeziorsk M., Watkins A., Hoyland J.A., Freemont A.J. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 2002, 55:91-97.
28. Yang C.L., Rui H., Mosler S., Notbohm H., Sawaryn A., Müller P.K. Collagen II from articular cartilage and annulus fibrosus: structural and functional implication of tissue specific posttranslational modifications of collagen molecules. Eur J Biochem 1993, 213:1297-1302.
29. Roughley P.J. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine 2004, 29:2691-2699.
30. Roughley P.J., Alini M., Antoniou J. The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. Biochem Soc Trans 2002, 30:869-874.
31. Cs-Szabo G., Ragasa-San Juan D., Turumella V., Masuda K., Thonar E.J., An H.S. Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. Spine 2002, 27:2212-2219.